|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| -0.29% | -1.68% | +22.62% | +78.29% | 58.81B | |
| -0.05% | +0.52% | +7.03% | +34.78% | 48.45B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 42.84B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 42.79B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.05B | |
| Average | -0.59% | -0.25% | +52.83% | +123.33% | 43.81B | |
| Weighted average by Cap. | -0.15% | -0.54% | +55.68% | +129.69% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
